{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "actinic keratoses",
      "cutaneous squamous cell carcinoma",
      "field cancerization",
      "keratinocyte carcinoma",
      "solid organ transplant recipient"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32387663",
  "DateCompleted": {
    "Year": "2021",
    "Month": "02",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "05",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jaad.2020.03.127",
      "S0190-9622(20)30792-1"
    ],
    "Journal": {
      "ISSN": "1097-6787",
      "JournalIssue": {
        "Volume": "83",
        "Issue": "3",
        "PubDate": {
          "Year": "2020",
          "Month": "Sep"
        }
      },
      "Title": "Journal of the American Academy of Dermatology",
      "ISOAbbreviation": "J Am Acad Dermatol"
    },
    "ArticleTitle": "Field cancerization: Treatment.",
    "Pagination": {
      "StartPage": "719",
      "EndPage": "730",
      "MedlinePgn": "719-730"
    },
    "Abstract": {
      "AbstractText": [
        "The goal of field cancerization treatment is to reduce the risk of developing keratinocyte carcinoma. Selecting the appropriate therapy depends on the degree of field cancerization and the number of invasive cutaneous squamous cell carcinomas. Other considerations include treatment efficacy, cost, side effects, and patient preference. Field therapies are preferred because they address clinically visible disease and subclinical atypia. However, lesion-directed therapies are useful for lesions that are more difficult to treat or those where a histologic diagnosis is required. Patients with extensive field cancerization benefit from a combination of field-directed and lesion-directed treatments. The second article in this continuing medical education series provides a framework to guide evidence-based decision making for field cancerization treatment."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts."
          }
        ],
        "LastName": "Cornejo",
        "ForeName": "Christine M",
        "Initials": "CM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School, Austin, Texas."
          }
        ],
        "LastName": "Jambusaria-Pahlajani",
        "ForeName": "Anokhi",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School, Austin, Texas."
          }
        ],
        "LastName": "Willenbrink",
        "ForeName": "Tyler J",
        "Initials": "TJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts."
          }
        ],
        "LastName": "Schmults",
        "ForeName": "Chrysalyne D",
        "Initials": "CD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, University of California San Francisco, San Francisco, California."
          }
        ],
        "LastName": "Arron",
        "ForeName": "Sarah T",
        "Initials": "ST"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: esruiz@bwh.harvard.edu."
          }
        ],
        "LastName": "Ruiz",
        "ForeName": "Emily S",
        "Initials": "ES"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Am Acad Dermatol",
    "NlmUniqueID": "7907132",
    "ISSNLinking": "0190-9622"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "143NQ3779B",
      "NameOfSubstance": "calcipotriene"
    },
    {
      "RegistryNumber": "FXC9231JVH",
      "NameOfSubstance": "Calcitriol"
    },
    {
      "RegistryNumber": "U3P01618RT",
      "NameOfSubstance": "Fluorouracil"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "J Am Acad Dermatol. 2021 Mar;84(3):e169",
      "PMID": "33137437"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Cutaneous"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Calcitriol"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Carcinoma, Basal Cell"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Clinical Decision-Making"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Combined Modality Therapy"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Cryosurgery"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Dermatology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Synergism"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Evidence-Based Medicine"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Fluorouracil"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Injections, Intralesional"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Keratosis, Actinic"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Medical Oncology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mohs Surgery"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Neoplasms, Second Primary"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Photochemotherapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Skin"
    },
    {
      "QualifierName": [
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Skin Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Skin Pigmentation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Ultraviolet Rays"
    }
  ]
}